Rajeev M. Shah, 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 1,909 shares at $7.99 ($14K) on 2022-08-04, disclosed to the SEC on 2022-08-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.48 | 1,809 | $14K | 94.4% |
| 2 | $7.99 | 100 | $799 | 5.6% |
| Total | $7.51 avg | 1,909 | $14K | 100% |
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |